Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleLetter to the Editor

MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy

TAYLOR AMERY, SHAADI TABATABAEI, MAYA SONPATKI, EVAN Y. YU and TOMASZ M. BEER
Anticancer Research May 2024, 44 (5) 2247-2248; DOI: https://doi.org/10.21873/anticanres.17033
TAYLOR AMERY
1Division of Medical Oncology, Oregon Health & Science University, Portland, OR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: amery{at}ohsu.edu
SHAADI TABATABAEI
1Division of Medical Oncology, Oregon Health & Science University, Portland, OR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAYA SONPATKI
2Department of Microbiology, Oregon State University, Corvallis, OR, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVAN Y. YU
3Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, U.S.A.;
4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMASZ M. BEER
1Division of Medical Oncology, Oregon Health & Science University, Portland, OR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Corrigenda - December 01, 2024
PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (5)
Anticancer Research
Vol. 44, Issue 5
May 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
TAYLOR AMERY, SHAADI TABATABAEI, MAYA SONPATKI, EVAN Y. YU, TOMASZ M. BEER
Anticancer Research May 2024, 44 (5) 2247-2248; DOI: 10.21873/anticanres.17033

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
TAYLOR AMERY, SHAADI TABATABAEI, MAYA SONPATKI, EVAN Y. YU, TOMASZ M. BEER
Anticancer Research May 2024, 44 (5) 2247-2248; DOI: 10.21873/anticanres.17033
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Acknowledgements
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Glymphatic Insights in Glioblastoma
  • Dual Role of Stratum Corneum Carotenes/Lycopene Against the Development of Chemotherapy-induced PPE in Patients With Cancer
Show more Letter to the Editor

Keywords

  • Prostate cancer
  • monoamine oxidase A
  • mCRPC
  • docetaxel
  • phenelzine
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire